BackVera Therapeutics Overview
Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics Target Price

Analysts' average 12-month price target for Vera Therapeutics is $87.

Get informed when a big investor buys or sells

+ Follow

Share Price

$34.99

Average Target Price

$86.75147.9% upside

8 analysts in the last 4 months

High: $125 | Low: $43

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-11Raymond JamesRyan Deschner$84140.1% upsideOpen
2026-07-08Wedbush$4322.9% upsideOpen
2026-07-08GuggenheimVamil Divan$76117.2% upsideOpen
2026-07-08Needham$125257.2% upsideOpen
2026-07-08H.C. Wainwright$125257.2% upsideOpen
2026-06-02JefferiesFarzin Haque$6071.5% upsideOpen
2026-06-02Goldman SachsPaul Choi$90157.2% upsideOpen
2026-05-15Evercore ISI$91160.1% upsideOpen
2025-12-19Goldman Sachs$95171.5% upsideOpen
2025-12-11WedbushLaura Chico$335.7% downsideOpen
2025-12-08Evercore ISIGavin Clark-Gartner$97177.2% upsideOpen
2025-12-05Pivotal Research$73108.6% upsideOpen
2025-11-28H.C. Wainwright$90157.2% upsideOpen
2025-06-03ScotiabankGreg Harrison$6585.8% upsideOpen
2024-03-21WedbushLaura Chico$342.8% downsideOpen
2024-01-26Raymond JamesRyan Deschner$375.7% upsideOpen
2023-12-18Raymond JamesRyan Deschner$2917.1% downsideOpen
2023-01-04Jefferies$682.9% downsideOpen
2023-01-04H.C. Wainwright$1557.1% downsideOpen
2022-11-18J.P. Morgan$388.6% upsideOpen
2022-05-02H.C. Wainwright$350% upsideOpen

Vera Therapeutics (VERA) FAQ

Vera Therapeutics (VERA) currently reports a target price of $87. Use the charts on this page to explore Vera Therapeutics's target price history and peer comparisons.

Analysts' average 12-month price target for Vera Therapeutics is $87, about 147.9% upside from the current share price of $34.99. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $87, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vera Therapeutics, and consider following VERA for alerts when major investors trade the stock.

Vera Therapeutics is classified in the Healthcare sector. On target price, it currently shows $87. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VERA with unrelated industries.